Gimet Labs: $58.0B valuation, IPO Readiness 68, Series H. Filed S-1 with the SEC on July 2026 — IPO actively in progress. Track live on The IPO Stack.
Applied AI research lab translating frontier AI capabilities into production-ready enterprise products.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Gimet Labs IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Gimet Labs filed its S-1 registration statement with the SEC on July 14, 2026. The IPO timeline depends on SEC review and market conditions. Track the latest signals on TechStackIPO.
Gimet Labs is valued at $58.0B as of the most recent funding round. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Accredited investors can access Gimet Labs shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.
Gimet Labs scores 68/100 (Grade: C) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Yes — Gimet Labs filed an S-1 registration statement with the SEC on July 14, 2026, indicating an active IPO process.
Gimet Labs has raised $2.65B in total venture capital and private equity funding, with backing from Menlo Ventures.
Gimet Labs's notable investors include Menlo Ventures. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
Gimet Labs is a AI Research company. Applied AI research lab translating frontier AI capabilities into production-ready enterprise products.